(PG) Procter Gamble - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7427181091
PG: Beauty, Grooming, Health, Fabric, Home, Baby, Feminine
At the heart of P&Gs success is its diverse portfolio, organized into five strategic segments, each a testament to the companys deep understanding of consumer needs. The Beauty segment, encompassing trusted brands like Pantene and Olay, offers a range of personal care products that are integral to daily routines worldwide. This segments resilience is bolstered by the consistent demand for skincare and haircare solutions, reflecting P&Gs commitment to innovation and customer satisfaction.
The Grooming segment further highlights P&Gs innovative spirit, with iconic brands such as Gillette leading the charge in shaving and grooming products. This segments focus on R&D underscores the companys dedication to staying ahead in a competitive market, offering investors a glimpse into a culture that values progress and consumer-centric solutions.
Health Care is another pillar of P&Gs strength, with Oral-B and Vicks being household names that signify trust and reliability. This segments emphasis on oral care and wellness products taps into the growing consumer awareness of health, positioning P&G as a key player in the personal health care sector.
Fabric & Home Care, a cornerstone of P&Gs offerings, boasts an array of beloved brands like Tide and Febreze. These products are not just market leaders but have become ingrained in daily life, offering a level of brand loyalty that is a rarity in todays competitive landscape. This segments success is a testament to P&Gs ability to deliver reliable, high-quality products that meet evolving consumer demands.
The Baby, Feminine & Family Care segment rounds out P&Gs portfolio with essential products from Pampers to Charmin. These offerings cater to fundamental needs, ensuring a steady revenue stream that underpins the companys financial stability. The recurring nature of these products makes this segment particularly attractive to investors seeking predictable returns.
Financially, P&G presents a compelling case with a market cap of over $380 billion, indicative of its market leadership and stability. While the current P/E ratio of 25.94 may seem elevated, the forward P/E of 24.69 suggests potential for future growth. The high P/B ratio of 7.96 reflects the markets valuation of P&Gs intangible assets, including its robust brand portfolio, while the P/S ratio of 4.53 highlights efficient revenue generation relative to its market cap.
In conclusion, Procter & Gambles enduring success
Additional Sources for PG Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PG Stock Overview
Market Cap in USD | 399,164m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Household Products |
IPO / Inception | 1970-01-01 |
PG Stock Ratings
Growth 5y | 68.0% |
Fundamental | 71.3% |
Dividend | 62.9% |
Rel. Strength Industry | -4.34 |
Analysts | 4.04/5 |
Fair Price Momentum | 173.71 USD |
Fair Price DCF | 164.72 USD |
PG Dividends
Dividend Yield 12m | 2.41% |
Yield on Cost 5y | 3.70% |
Annual Growth 5y | 4.90% |
Payout Consistency | 99.5% |
PG Growth Ratios
Growth Correlation 3m | -53.4% |
Growth Correlation 12m | 66.1% |
Growth Correlation 5y | 89.9% |
CAGR 5y | 9.32% |
CAGR/Max DD 5y | 0.39 |
Sharpe Ratio 12m | 0.33 |
Alpha | 3.55 |
Beta | 0.05 |
Volatility | 23.73% |
Current Volume | 6301.7k |
Average Volume 20d | 6707.2k |
As of February 22, 2025, the stock is trading at USD 170.23 with a total of 6,301,743 shares traded.
Over the past week, the price has changed by +4.51%, over one month by +5.90%, over three months by -0.86% and over the past year by +8.75%.
Yes, based on ValueRay Fundamental Analyses, Procter Gamble (NYSE:PG) is currently (February 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 71.30 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PG as of February 2025 is 173.71. This means that PG is currently overvalued and has a potential downside of 2.04%.
Procter Gamble has received a consensus analysts rating of 4.04. Therefor, it is recommend to buy PG.
- Strong Buy: 13
- Buy: 4
- Hold: 10
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, PG Procter Gamble will be worth about 187.6 in February 2026. The stock is currently trading at 170.23. This means that the stock has a potential upside of +10.21%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 178.7 | 5% |
Analysts Target Price | 180.4 | 6% |
ValueRay Target Price | 187.6 | 10.2% |